Connor Clark & Lunn Investment Management Ltd. Makes New $1.62 Million Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 12,195 shares of the company's stock, valued at approximately $1,622,000. Connor Clark & Lunn Investment Management Ltd. owned about 0.07% of Addus HomeCare at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. UMB Bank n.a. raised its position in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after acquiring an additional 88 shares during the last quarter. Quest Partners LLC acquired a new position in Addus HomeCare during the 2nd quarter valued at about $31,000. EntryPoint Capital LLC bought a new position in shares of Addus HomeCare in the 1st quarter valued at about $44,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $44,000. Finally, Farther Finance Advisors LLC raised its stake in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after buying an additional 366 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Shares of ADUS traded up $1.46 during mid-day trading on Tuesday, hitting $124.41. 130,280 shares of the company's stock were exchanged, compared to its average volume of 131,677. The company has a market cap of $2.26 billion, a PE ratio of 28.32, a P/E/G ratio of 2.17 and a beta of 1.04. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12. The company has a 50-day simple moving average of $128.07 and a 200 day simple moving average of $123.41.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period in the prior year, the business posted $1.03 EPS. The company's quarterly revenue was up 7.1% on a year-over-year basis. On average, analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Esteban Lopez sold 500 shares of the firm's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 12.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 4.60% of the company's stock.

Analyst Ratings Changes

Several brokerages have commented on ADUS. Macquarie reiterated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Stephens increased their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. Oppenheimer boosted their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Monday, September 23rd. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an "overweight" rating and a $150.00 price objective on the stock. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.